RPS15P9

Across TCGA pan-cancer cohorts, RPS15P9 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RPS15P9 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RPS15P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS15P9 expression acts as an unfavorable survival marker, although some lineages such as SKCM and COAD show a favorable association.

KICH, CHOL, and STAD are the cancer types where RPS15P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.775	0.986	<.001	102	view →
CHOL	OS	Tertile	All	0.057	0.723	<.001	54	view →
STAD	DFS	Quartile	II,III,IV	0.355	0.735	.004	38	view →
SKCM	OS	Tertile	All	0.887	0.729	.004	30	view →
COAD	OS	Quartile	II,III,IV	0.803	0.544	.004	25	view →
LIHC	DFS	Tertile	All	0.200	0.482	<.001	24	view →
KIRC	DFS	Median	IV	0.304	0.583	.016	20	view →
ACC	DFS	Tertile	III,IV	0.833	0.350	.012	15	view →
OV	OS	Tertile	II,III,IV	0.264	0.388	.015	12	view →
READ	OS	Tertile	IV	0.428	0.735	.027	11	view →
PAAD	OS	Tertile	All	0.401	0.625	.010	9	view →
ESCA	DFS	Tertile	IV	0.704	0.252	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RPS15P9–KICH (OS)

Open the KICH breakdown →